Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 167

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Orally available compound prevents deficits in memory caused by the Alzheimer amyloid‐β oligomers

Townsend, Matthew, Cleary, James P., Mehta, Tapan, Hofmeister, Jacki, Lesne, Sylvain, O'Hare, Eugene, Walsh, Dominic M., Selkoe, Dennis J.·2006·Annals of Neurology

Abstract

Objective: Despite progress in defining a pathogenic role for amyloid β protein (Aβ) in Alzheimer's disease, orally bioavailable compounds that prevent its effects on hippocampal synaptic plasticity and cognitive function have not yet emerged. A particularly attractive therapeutic strategy is to selectively neutralize small, soluble Aβ oligomers that have recently been shown to mediate synaptic dysfunction. Methods: Using electrophysiological, biochemical, and behavioral assays, we studied how scyllo‐inositol (AZD‐103; molecular weight, 180) neutralizes the acutely toxic effects of Aβ on synaptic function and memory recall. Results: Scyllo‐inositol, but not its stereoisomer, chiro‐inositol, dose‐dependently rescued long‐term potentiation in mouse hippocampus from the inhibitory effects of soluble oligomers of cell‐derived human Aβ. Cerebroventricular injection into rats of the soluble Aβ oligomers interfered with learned performance on a complex lever‐pressing task, but administration of scyllo‐inositol via the drinking water fully prevented oligomer‐induced errors. Interpretation: A small, orally available natural product penetrates into the brain in vivo to rescue the memory impairment produced by soluble Aβ oligomers through a mechanism that restores hippocampal synaptic plasticity. Ann Neurol 2006;60:668–676

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.21051

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 167

Metadata

Authors
Townsend, M., Cleary, J. P., Mehta, T., Hofmeister, J., Lesne, S., O'Hare, E., Walsh, D. M., & Selkoe, D. J.
Venue
Annals of Neurology
Publisher
Wiley
Published
2006-12
Volume
60
Issue
6
Pages
668-676
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W2050529442
Cited by
167
References
4
FWCI
9.41
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Orally available compound prevents deficits in memory caused by the Alzheimer amyloid‐β oligomers. https://app.cochat.ai/papers/10.1002/ana.21051
The paper
Townsend, M., Cleary, J. P., Mehta, T., Hofmeister, J., Lesne, S., O'Hare, E., Walsh, D. M., & Selkoe, D. J. (2006). Orally available compound prevents deficits in memory caused by the Alzheimer amyloid‐β oligomers. Annals of Neurology. https://doi.org/10.1002/ana.21051

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.